ELISA: React with human MCP-1. Matched pair antibodies are available. Neutralizing: Tests on the ability to inhibit monocyte chemotaxis toward 1 nM recombinanthuman MCP-1 in blindwell chambers showed that the antibodies were particularly effectiveat blocking MCP-1 activity at a concentration of 0.5 μg/mL. It was also found that S-14 couldinhibit the function of native MCP-1 at concentrations similar to inhibitory doses forrecombinant MCP-1. Western Blot: Concentration of 0.1-1.0 μg/mL will allow visualization of 0.1 μg/lane ofhuman MCP-1. Concentration of 5.0 μg/mL will allow visualization of 50 μg/lane of rabbitMCP-1. Other applications not tested. Optimal dilutions are dependent on conditions and should be determined by the user.
Restrictions
For Research Use only
Reconstitution
Restore with Double distillated water to adjust the final concentration to 1.0 mg/mL.
Concentration
1.0 mg/mL
Buffer
0.01 M PBS, pH 7.2 without preservatives
Preservative
Without preservative
Handling Advice
Avoid repeated freezing and thawing.
Storage
-20 °C
Target
CCL2
(Chemokine (C-C Motif) Ligand 2 (CCL2))
Alternative Name
MCP1 / CCL2
Background
Monocyte chemotactic and activating factor (MCAF) is also called monocyte chemotactic protein-1 (MCP-1) and chemokine (C-C motif) ligand 2 (CCL2). It is primarily secreted by monocytes, macrophages and dendritic cells. This cytokine displays chemotactic activity for monocytes, T-cells, and basophils, but not for neutrophils or eosinophils. MCAF causes the degranulation of basophils and mast cells, and augments the activity of monocyte and macrophage. MCAF plays an important role in inflammation, angiogenesis, autoimmune diseases, renal diseases, chronic infection and granuloma formation.Synonyms: C-C motif chemokine 2, HC-11, HC11, MCAF, MCP-1, Monocyte chemoattractant protein 1, Monocyte chemotactic and activating factor, Monocyte chemotactic protein 1, Monocyte secretory protein JE, SCYA2, Small-inducible cytokine A2